Broad-based molecular autopsy: A potential tool to investigate the involvement of subtle cardiac conditions in sudden unexpected death in infancy and early childhood

Archives of Disease in Childhood

Volumn 100, Issue 10, 2015, Pages 952-956

  Santori, Montserrat ^a,b,c   Blanco Verea, Alejandro ^a,b,c   Gil, Rocio ^a,b,c   Cortis, Judith ^d   Becker, Katrin ^d   Schneider, Peter M ^d   Carracedo, Angel ^b,c,e   Brion, Maria ^a,b,c  

^a Santiago University Clinical Hospital   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c Instituto de Investigación Sanitaria de Santiago de Compostela IDIS   (Spain)

^d UNIVERSITY OF COLOGNE   (Germany)

^e KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA DISEASE; ARTICLE; AUTOPSY; CARDIOMYOPATHY; CAUSE OF DEATH; CHANNELOPATHY; CHILD; CHILD DEATH; CLINICAL ARTICLE; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; INFANT; MALE; MOLECULAR AUTOPSY; NEXT GENERATION SEQUENCING; PATHOGENICITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUDDEN CARDIAC DEATH; SUDDEN DEATH; DEATH, SUDDEN, CARDIAC; GENETICS; HEART DISEASE; MORTALITY; PRESCHOOL CHILD; PROCEDURES; SUDDEN INFANT DEATH;

AUTOPSY; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN, CARDIAC; HEART DISEASES; HUMANS; INFANT; SUDDEN INFANT DEATH;

EID: 84942981947     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2015-308200     Document Type: Article

References (35)

1. Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 2013;10:1932-63.
2. Wong LCH, Behr ER. Sudden unexplained death in infants and children: the role of undiagnosed inherited cardiac conditions. Europace 2014;16:1706-13.
3. Krous HF, Beckwith JB, Byard RW, et al. Sudden infant death syndrome and unclassified sudden infant deaths: a definitional and diagnostic approach. Pediatrics 2004;114:234-8.
4. Instituto Nacional de Estadística. http://www.ine.es/(accessed 14 January 2015).
5. Schwartz PJ, Stramba-Badiale M, Segantini A, et al. Prolongation of the QT interval and the sudden infant death syndrome. New Engl J Med 1998;338:1709-14.
6. Brugada R, Hong K, Dumaine R, et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 2004;109:30-5.
7. Wilders R. Cardiac ion channelopathies and the sudden infant death syndrome. ISRN Cardiol 2012;2012:846171.
8. Tester DJ, Ackerman MJ. Cardiac channelopathies and the molecular autopsy. In: Collins K, Byard R, eds. Forensic pathology of infancy and childhood. Springer, 2014:899-942.
9. Brion M, Allegue C, Santori M, et al. Sarcomeric gene mutations in sudden infant death syndrome (SIDS). Forensic Sci Int 2012;219:278-81.
10. Brion M, Blanco-Verea A, Sobrino B, et al. Next generation sequencing challenges in the analysis of cardiac sudden death due to arrhythmogenic disorders. Electrophoresis 2014;35:3111-16.
11. Ng D, Johnston JJ, Teer JK, et al. Interpreting secondary cardiac disease variants in an exome cohort. Circ Cardiovasc Genet 2013;6:337-46.
12. Liu B, Tikunova SB, Kline KP, et al. Disease-related cardiac troponins alter thin filament Ca2+ association and dissociation rates. PLoS ONE 2012;7:e38259.
13. Crilley JG, Boehm EA, Blair E, et al. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. J Am Coll Cardiol 2003;41:1776-82.
14. Witjas-Paalberends ER, Güçlü A, Germans T, et al. Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations. Cardiovasc Res 2014;103:248-57.
15. Poetter K, Jiang H, Hassanzadeh S, et al. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 1996;13:63-9.
16. Andersen PS, Havndrup O, Bundgaard H, et al. Myosin light chain mutations in familial hypertrophic cardiomyopathy: phenotypic presentation and frequency in Danish and South African populations. J Med Genet 2001;38:e43.
17. Lopes LR, Zekavati A, Syrris P, et al. Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing. J Med Genet 2013;50:228-39.
18. Mook OR, Haagmans MA, Soucy JF, et al. Targeted sequence capture and GS-FLX Titanium sequencing of 23 hypertrophic and dilated cardiomyopathy genes: implementation into diagnostics. J Med Genet 2013;50:614-26.
19. Farman GP, Muthu P, Kazmierczak K, et al. Impact of familial hypertrophic cardiomyopathy-linked mutations in the NH2 terminus of the RLC on ?-myosin cross-bridge mechanics. J Appl Physiol (1985) 2014;117:1471-7.
20. Szczesna D, Ghosh D, Li Q, et al. Familial hypertrophic cardiomyopathy mutations in the regulatory light chains of myosin affect their structure, Ca2+ binding, and phosphorylation. J Biol Chem 2001;276:7086-92.
21. Kazmierczak K, Muthu P, Huang W, et al. Myosin regulatory light chain mutation found in hypertrophic cardiomyopathy patients increases isometric force production in transgenic mice. Biochem J 2012;442:95-103.
22. Lange S, Xiang F, Yakovenko A, et al. The kinase domain of titin controls muscle gene expression and protein turnover. Science 2005;308:1599-603.
23. Chauveau C, Bonnemann CG, Julien C, et al. Recessive TTN truncating mutations define novel forms of core myopathy with heart disease. Hum Mol Genet 2013;23:980-91.
24. Pfeffer G, Barresi R, Wilson IJ, et al. Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure. J Neurol Neurosurg Psychiatry 2014;85:331-8.
25. Ohlsson M, Hedberg C, Brådvik B, et al. Hereditary myopathy with early respiratory failure associated with a mutation in A-band titin. Brain 2012;135:1682-94.
26. Camfield P, Camfield C. Sudden unexpected death in people with epilepsy: a pediatric perspective. Semin Pediatr Neurol 2005;12:10-14.
27. Vestergaard M, Pedersen MG, Østergaard JR, et al. Death in children with febrile seizures: a population-based cohort study. Lancet 2008;372:457-63.
28. Knieriem HJ. Electron-microscopic findings in congestive cardiomyopathy. In: Kaltenbach M, Loogen F, Olsen EGJ, eds. Cardiomyopathy and myocardial biopsy. Berlin Heidelberg: Springer, 1978:71-86.
29. Remme CA. Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects. J Physiol 2013;591(Pt 17): 4099-116.
30. Wang DW, Desai RR, Crotti L, et al. Cardiac sodium channel dysfunction in sudden infant death syndrome. Circulation 2007;115:368-76.
31. Linke WA, Hamdani N. Gigantic business titin properties and function through thick and thin. Circul Res 2014;114:1052-68.
32. Herman DS, Lam L, Taylor MRG, et al. Truncations of titin causing dilated cardiomyopathy. N Engl J Med 2012;366:619-28.
33. MacArthur DG, Manolio TA, Dimmock DP, et al. Guidelines for investigating causality of sequence variants in human disease. Nature 2014;508:469-76.
34. Golbus JR, Puckelwartz MJ, Fahrenbach JP, et al. Population-based variation in cardiomyopathy genes. Circ Cardiovasc Genet 2012;5:391-9.
35. Cooper DN, Krawczak M, Polychronakos C, et al. Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Hum Genet 2013;132:1077-130.